Regulatory News
Thursday, January 26, 2017
Teva's Barr Labs settles Cipro antitrust case for $225 mln
Jan 26 (Reuters) - Teva Pharmaceutical Industries Ltd's
Barr Laboratories Inc has reached a $225 million
settlement in an antitrust class action that accused the
drugmaker of keeping a generic...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment